Conrig Pharma
-
2010
Company Description
Conrig Pharma ApS engages in development of drug for oral treatment of atopical dermatitis
Conrig Pharma will reposition drug molecules with attractive safety and efficacy profiles through simple modifications and reformulations to provide fast development of new treatments of illnesses. Initial focus will be on a development of a new drug for oral treatment of atopic dermatitis (a type of eczema).
-
Manufacturer:
Science and Engineering -
Formed:
2010 -
Company Website:
-
Company E-mail:
-
Company Address:
Conrig Pharma ApS, Langaasen 3JyderupDenmark -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits